Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions

Cell. 2023 Aug 31;186(18):3793-3809.e26. doi: 10.1016/j.cell.2023.07.017. Epub 2023 Aug 9.

Abstract

Hepatocytes, the major metabolic hub of the body, execute functions that are human-specific, altered in human disease, and currently thought to be regulated through endocrine and cell-autonomous mechanisms. Here, we show that key metabolic functions of human hepatocytes are controlled by non-parenchymal cells (NPCs) in their microenvironment. We developed mice bearing human hepatic tissue composed of human hepatocytes and NPCs, including human immune, endothelial, and stellate cells. Humanized livers reproduce human liver architecture, perform vital human-specific metabolic/homeostatic processes, and model human pathologies, including fibrosis and non-alcoholic fatty liver disease (NAFLD). Leveraging species mismatch and lipidomics, we demonstrate that human NPCs control metabolic functions of human hepatocytes in a paracrine manner. Mechanistically, we uncover a species-specific interaction whereby WNT2 secreted by sinusoidal endothelial cells controls cholesterol uptake and bile acid conjugation in hepatocytes through receptor FZD5. These results reveal the essential microenvironmental regulation of hepatic metabolism and its human-specific aspects.

Keywords: FZD5; WNT2; bile acid conjugation; cholesterol; fibrosis; humanized liver; lipidomics; liver sinusoidal endothelial cells; non-alcoholic fatty liver disease; stellate cells.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endothelial Cells* / metabolism
  • Fibrosis / metabolism
  • Hepatocytes / metabolism
  • Humans
  • Kupffer Cells / metabolism
  • Liver* / cytology
  • Liver* / metabolism
  • Mice
  • Non-alcoholic Fatty Liver Disease / metabolism